By Miles CooperOctober 19, 2025 Business FDA Delays Decision on Lilly’s Alzheimer’s Drug, Sets Date for Advisory Panel Review
By Mia GarciaJuly 14, 2025 Business FDA Issues Warning Letter to Dexcom Over Manufacturing Practices at Two U.S. Facilities